Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia

NCT01779167 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG: Thalidomide
DRUG: Lenalidomide
DRUG: Rituximab

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]